» Articles » PMID: 35035444

Effects of Enteral Nutrition on Heart Function, Inflammatory Markers and Immune Function in Elderly Patients with Chronic Heart Failure

Overview
Journal Pak J Med Sci
Specialty General Medicine
Date 2022 Jan 17
PMID 35035444
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the effect of enteral nutrition on heart function, inflammatory markers and immune function in elderly patients with chronic heart failure and its clinical significance.

Methods: Eighty patients with moderate and severe heart failure admitted to the Cardiology Intensive Care Unit (CCU) of Baoding First Central Hospital from May 2019 to May 2020 were included in this study and randomly divided into two groups: the experimental group and the control group, with 40 patients in each group. The experimental group was given enteral nutrition support therapy on the basis of conventional therapy for one month, while the control group was given restricted salt and water intake on the basis of conventional therapy, and patients were given free diet according to their wishes. The changes in heart function before and after treatment, changes in inflammatory factors such as TNF-a, CRP, IL-6, changes in levels of immunoglobulins such as IgA, IgM, and IgG, and the improvement of the performance status of the two groups were compared and analyzed.

Results: After treatment, indicators such as BNP, LVEDD, LVEF and 6min walking distance in the experimental group were significantly improved compared with the control group, with statistically significant differences (p<0.05), and the levels of inflammatory factors such as TNF-a, CRP and IL-6 in the experimental group were significantly reduced compared with those in the control group (p=0.00). The levels of IgG, IgA, IgM and other immunoglobulins in the experimental group improved more significantly after treatment than those in the control group, with statistically significant differences (IgG, IgA, p=0.00; IgM, p=0.01). Moreover, the experimental group was significantly superior to the control group in the improvement rate of performance status score (ECOG) after treatment (p=0.04); The incidence of gastrointestinal adverse reactions in the experimental group was 20%, and that in the control group was 15%. No statistically significant difference can be observed in the gastrointestinal tolerance of both groups (p=0.56).

Conclusions: Reasonable enteral nutrition boasts a variety of benefits for the recovery of elderly patients with chronic heart failure. With reasonable enteral nutrition, the heart function of elderly patients with chronic heart failure can be significantly improved, inflammatory factors can be reduced, immunity and performance status can be enhanced, and gastrointestinal tolerance can be ameliorated without obvious gastrointestinal reactions.

Citing Articles

Study on the clinical efficacy, safety and compliance of quality nursing intervention in the treatment of chronic heart failure combined with respiratory tract infections.

Jia Y, Li N, Zhang X, Lu Z, You X, Xu Q Pak J Med Sci. 2024; 40(7):1533-1538.

PMID: 39092044 PMC: 11255804. DOI: 10.12669/pjms.40.7.7873.

References
1.
Kitzman D, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus W . Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2016; 315(1):36-46. PMC: 4787295. DOI: 10.1001/jama.2015.17346. View

2.
Chung M, Park L, Frazier S, Lennie T . Long-Term Adherence to Low-Sodium Diet in Patients With Heart Failure. West J Nurs Res. 2016; 39(4):553-567. DOI: 10.1177/0193945916681003. View

3.
Skrzypek A, Mostowik M, Szeliga M, Wilczynska-Golonka M, Debicka-Dabrowska D, Nessler J . Chronic heart failure in the elderly: still a current medical problem. Folia Med Cracov. 2019; 58(4):47-56. View

4.
Murphy S, Ibrahim N, Januzzi Jr J . Heart Failure With Reduced Ejection Fraction: A Review. JAMA. 2020; 324(5):488-504. DOI: 10.1001/jama.2020.10262. View

5.
Hansen P, Nelveg-Kristensen K, Rasmussen H, Torp-Pedersen C, Kober L, Nielsen C . Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure. Pharmacogenomics J. 2019; 19(5):428-437. DOI: 10.1038/s41397-019-0068-2. View